US Trade Office Signals Growing Drug Counterfeiting Problem

An Office of the US Trade Representative (USTR) report says that pharmaceutical products and active pharmaceutical ingredients bearing counterfeit trademarks is a “growing problem” and the majority of counterfeit pharmaceuticals seized at the US borders in fiscal year 2018 were shipped from China, Hong Kong, India and Vietnam.

The USTR’s annual “Special 301 Report” , which was released on 25 April, analyzes the adequacy and effectiveness of trading partners’ protection of intellectual property rights (IPR) and placed...